Evidence map›Paper›PMID 32530971›Full record

ArticlePloS one2020

Natural transformation of the filamentous cyanobacterium Phormidium lacuna.

Fabian Nies, Marion Mielke, Janko Pochert, Tilman Lamparter

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Metagenome-Assembled Genomes for "Microbiology resource announcements · 2022
    Article
  11. Article
  12. Engineering Natural Competence into the Fast-Growing CyanobacteriumApplied and environmental microbiology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fabian NiesBotanical Institute, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Marion MielkeBotanical Institute, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Janko PochertBotanical Institute, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Tilman LamparterBotanical Institute, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.ORCID 0000-0003-4327-9737

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research for biotechnological applications of cyanobacteria focuses on synthetic pathways and bioreactor design, while little effort is devoted to introduce new, promising organisms in the field. Applications are most often based on recombinant work, and the establishment of transformation can be a risky, time-consuming procedure. In this work we demonstrate the natural transformation of the filamentous cyanobacterium Phormidium lacuna and insertion of a selection marker into the genome by homologous recombination. This is the first example for natural transformation filamentous non-heterocystous cyanobacterium. We found that Phormidium lacuna is polyploid, each cell has about 20-90 chromosomes. Transformed filaments were resistant against up to 14 mg/ml of kanamycin. Formerly, natural transformation in cyanobacteria has been considered a rare and exclusive feature of a few unicellular species. Our finding suggests that natural competence is more distributed among cyanobacteria than previously thought. This is supported by bioinformatic analyses which show that all protein factors for natural transformation are present in the majority of the analyzed cyanobacteria.

Indexed as

Homologous RecombinationTransformation, BacterialChromosomes, BacterialComputational BiologyCyanobacteriaDrug Resistance, BacterialGenome, BacterialKanamycinPolyploidyKanamycin

Identifiers

PMID32530971
PMCPMC7292380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.